SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-048977
Filing Date
2019-09-09
Accepted
2019-09-09 19:35:32
Documents
2
Period of Report
2019-09-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1620
2 POA DOCUMENT poa.txt EX-24.3_871805 2996
  Complete submission text file 0001209191-19-048977.txt   6125
Mailing Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Issuer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ONCTERNAL THERAPEUTICS, INC. 12230 EL CAMINO REAL, SUITE 300 SAN DIEGO CA 92130
Business Address
Kaufmann Gunnar F. (Reporting) CIK: 0001786754 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50549 | Film No.: 191084072